Live
Endpoints NewsLilly points to low-dose Zepbound and Foundayo as weight loss maintenance optionsIlluminaThe Bull Case For Illumina (ILMN) Could Change Following Upgraded 2026 Outlook And Major Buyback - Learn Why - simplywall.stSiemens HealthineersA Look At Siemens Healthineers (XTRA:SHL) Valuation After New HKSH Photon‑Counting CT Partnership - simplywall.stFierceBiotechFDA Commissioner Marty Makary to resign, capping turbulent tenure: reportFierceBiotechKyverna begins rolling submission for autoimmune CAR-T as FDA requests more natural history analysisClinical OMICsLow‑Dose Digoxin Shows Benefit in Heart Failure TreatmentCharles RiverCharles River Laboratories stock (US1591881009): Q1 earnings beat but FY2026 forecast cut - AD HOC NEWSClinical OMICsAntibody Promotes Nerve Regeneration in Spinal Cord Injury PatientsClinical OMICsSingle Procedure Reduces Colorectal Cancer Risk Decades Later10x Genomics News10x Genomics settles suit with rival and targets DNA sequencing startup - Life Sciences Intellectual Property ReviewClinical OMICsFirst Clinical Trial for a GLP-1 Gene Therapy Greenlit in EuropeBioPharma DiveFDA chief Marty Makary resigns from agency, ending tumultuous tenure
Agilent Mar 27, 2026

Agilent Technologies Inc. stock outperforms competitors despite losses on the day - MarketWatch

Agilent Technologies Inc. stock outperforms competitors despite losses on the day - MarketWatch

Body unavailable. Use the original source.